Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Century Therapeutics, Inc. (IPSC) had Stock-Based Compensation of $5.54M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-34.42M |
|
-- |
|
-- |
|
$36.12M |
|
$-36.12M |
|
$1.70M |
|
$-34.42M |
|
$-34.42M |
|
$-34.42M |
|
$-34.42M |
|
$-34.42M |
|
$-34.42M |
|
$-36.12M |
|
$-33.50M |
|
86.46M |
|
86.46M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$137.71M |
|
$53.72M |
|
$107.01M |
|
$244.72M |
|
$22.03M |
|
-- |
|
$46.34M |
|
$68.37M |
|
$176.35M |
|
$142.15M |
|
$176.35M |
|
86.53M |
|
| Cash Flow Statement Financials | |
$-87.80M |
|
$85.14M |
|
$0.12M |
|
$61.21M |
|
$58.67M |
|
$-2.54M |
|
|
Stock-Based Compensation |
$5.54M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.25 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-88.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.52% |
|
-24.22% |
|
-14.07% |
|
-19.52% |
|
$2.04 |
|
$-1.03 |
|
$-1.02 |
|